1. Home
  2. |Insights
  3. |ASBCA Clarifies SOL on Interest Claims Under the Prompt Payment Act

ASBCA Clarifies SOL on Interest Claims Under the Prompt Payment Act

Client Alert | less than 1 min read | 05.23.16

In Public Warehousing Co. (May 2, 2016), the Board held the CDA statute of limitations on a contractor’s claim for interest penalties under the Prompt Payment Act does not accrue until the government makes the underlying payment. Rejecting the government’s argument that the interest claim should accrue as soon as government fails to make the underlying payment, the Board held that, under the PPA, “the events that fix the government's alleged liability and allow a claim for interest penalties to be asserted do not occur until the government pays the underlying invoice without paying the interest penalty due.”

Insights

Client Alert | 6 min read | 09.03.26

FDA Seeks Input for Regulating GenAI-Powered Medical Devices

The U.S. Food & Drug Administration (FDA) is seeking feedback on a regulatory framework that could be used to evaluate generative artificial intelligence (GenAI)-enabled medical devices. Such devices could create new types of risks because their outputs can vary and evolve, unlike more traditional software-enabled devices. An August 18, 2026, discussion paper (“Considerations for the regulation of GenAI-enabled medical devices”) discusses potential regulatory considerations for GenAI-enabled medical devices. ...